Skip to content

Can HIV cure trials strike a balance between the need for meaningful data and participant safety?

Elle Aon/Shutterstock.com

Pregnant and breastfeeding cis women are paying the price for exclusion from PrEP research

Syda Productions/Shutterstock.com

Women living with HIV are under-represented in research, limiting our understanding of co-morbid diseases

Dr Sonia Raffe presenting to EACS 2021.

“Why are we being used like guinea pigs?” Transgender women’s mistrust of PrEP research

The Gender Spectrum Collection. Image is for illustrative purposes only.

Treatment interruption in cure research is associated with greater risk of non-AIDS related events in the long term, Spanish study finds

Dragana Gordic/Shutterstock.com

New ethical obligations for researchers in places where existing HIV prevention services are inadequate

Peter Godfrey-Faussett (top right) presenting at HIVR4P 2021.

I’m living with HIV and have had the COVID vaccine

Michael Carter | Olena Yakobchuk/Shutterstock.com

Biological, clinical and ethical imperatives for involving diverse women in HIV clinical trials

Dr Catherine Orrell presenting to HIV Glasgow 2020.

Malawian women keen to join HIV prevention trials during pregnancy

'The next generation of mums in Malawi'. Lindsay Mgbor/Department for International Development. Creative Commons licence. Image for illustrative purposes only.